TXT In plain English
Company description
UCB PHARMA LIMITED is a UK company whose Companies House status is “Active” and whose registered company type is “Private Limited Company”. Incorporated on 24 November 1925; registered for 100 years; registered office reported in BERKSHIRE. Its primary declared activity is 21100 · Manufacture of basic pharmaceutical products.
This BritDB profile also contains linked public records: 1 PSC record, 21 trade marks, 13 procurement records. This description is assembled from public data, is not a reliability assessment, and should be checked against the cited sources before a legally significant decision.
Web facts are never added from a name match alone. Internet enrichment requires the exact Companies House ID in Wikidata, and ambiguous results are excluded.
01 Company overview
Identity and registration
- Official name
- UCB PHARMA LIMITED
- Company number
- 00209905
- Company type
- Private Limited Company
- Status
- Active
- Country of origin
- United Kingdom
- Dissolution date
- Not supplied
- Accounts category
- FULL
- Mortgage charges
- 7 total · 0 outstanding · 7 satisfied
- Limited partnership members
- 0 general · 0 limited
A registered office is not necessarily a trading location. The address is reproduced from the Companies House bulk record and should be interpreted in that legal context.
02 Filing dates
Accounts and statements
Last accounts made up to
31 December 2025Next accounts due
30 September 2027Last statement made up to
12 May 2026Next statement due
26 May 2027BritDB does not infer overdue status when the source does not state it.
03 Supplier payments
Payment practices and performance
- Reporting period
- 1 January 2026 – 30 June 2026
- Filed
- 21 July 2026
- Shortest standard term
- 15 days
- Longest standard term
- 90 days
- E-invoicing offered
- Yes
- Supply-chain finance
- Not offered
- Payment codes
- No
- Construction retentions
- No qualifying construction contracts
Complete reported payment fields
- Policy regime
- Regime-3
- Financial period started
- 1 January 2026
- Qualifying contracts
- Yes
- Payments made
- Yes
- Invoice value paid within 30 days
- £160,759
- Invoice value paid in 31–60 days
- £3,319,722
- Invoice value paid after 60 days
- £373,672
- Invoice value paid outside agreed terms
- £3,854,153
- Invoices paid in 31–60 days
- 49.0%
- Invoices unpaid due to dispute
- 0.0%
- Maximum contractual payment period
- 90 days
- Supplier-list charging policy
- No
- Supplier-list charges made
- No
Reported terms and dispute process
- Standard payment terms
UCB payment terms are 60 days for most vendors. Some vendors are paid on 30 days term.
- Dispute resolution process
Any complaints regarding payment are to be logged with our account payables helpdesk. It will be then raised with the payment team and cause, and resolution will be investigated. If there is any escalation it will be referred to the local account payables lead.
Earlier payment reports (11 shown)
- 50.0 average days to pay8.0% outside terms
- 50.0 average days to pay0.0% outside terms
- 48.0 average days to pay8.0% outside terms
- 43.0 average days to pay4.0% outside terms
- 49.0 average days to pay7.0% outside terms
- 53.0 average days to pay16.0% outside terms
- 51.0 average days to pay12.0% outside terms
- 51.0 average days to pay12.0% outside terms
- 49.0 average days to pay7.0% outside terms
- 49.0 average days to pay11.0% outside terms
- 51.0 average days to pay9.0% outside terms
This is a company-submitted statutory disclosure, not a credit rating. BritDB preserves the reporting period and links the report only through the Companies House number supplied by the official service. Percentages describe payments made during that period and may change in later reports.
04 Global legal identity
Legal Entity Identifier
UCB PHARMA LIMITED
LEI 21380083DWCEAVWH1W57 · jurisdiction GB
- Legal form
- H0PO
- Entity category
- GENERAL
- Entity created
- 24 November 1995
- Initial LEI registration
- 5 February 2014
- LEI last updated
- 13 January 2026
- Next renewal
- 11 March 2027
- Managing LOU
- 213800WAVVOPS85N2205
- Legal address
- 208 BATH ROAD, SLOUGH, GB-SLG, SL1 3WE, GB
- Headquarters address
- 208 BATH ROAD, SLOUGH, GB-SLG, SL1 3WE, GB
GLEIF Level 2 relationships
IS DIRECTLY CONSOLIDATED BY
From LEI 21380083DWCEAVWH1W57 to LEI 2138008J191VLSGY5A09
- Initial registration
- 5 February 2014
- Last updated
- 13 January 2026
- Next renewal
- 11 March 2027
- Validation sources
- ENTITY_SUPPLIED_ONLY
- Validation documents
- OTHER_OFFICIAL_DOCUMENTS
- Relationship periods
- Start: 2019-01-01T00:00:00Z; End: 2019-12-31T00:00:00Z; Type: ACCOUNTING_PERIOD; Start: 2014-02-05T00:00:00Z; Type: RELATIONSHIP_PERIOD
- Qualifiers
- Dimension: ACCOUNTING_STANDARD; Category: OTHER_ACCOUNTING_STANDARD
- Validation reference
- Not supplied
IS ULTIMATELY CONSOLIDATED BY
From LEI 21380083DWCEAVWH1W57 to LEI 2138008J191VLSGY5A09
- Initial registration
- 5 February 2014
- Last updated
- 13 January 2026
- Next renewal
- 11 March 2027
- Validation sources
- FULLY_CORROBORATED
- Validation documents
- ACCOUNTS_FILING
- Relationship periods
- Start: 2019-01-01T00:00:00Z; End: 2019-12-31T00:00:00Z; Type: ACCOUNTING_PERIOD; Start: 2014-02-05T00:00:00Z; Type: RELATIONSHIP_PERIOD
- Qualifiers
- Dimension: ACCOUNTING_STANDARD; Category: IFRS
- Validation reference
- https://reports.ucb.com/2019/integrated-annual-report/servicepages/downloads/files/entire_en_ucb_ir19.pdf
LEI data provides global legal identity and source-reported relationships, not a credit or regulatory approval. BritDB links Level 1 identities only through GLEIF’s Companies House registration-authority identifier and exact company number; Level 2 parent and fund relationships and reporting exceptions are reproduced as supplied by GLEIF.
05 Supply-chain transparency
Modern slavery statement
- Organisation
- UCB PHARMA LIMITED
- Group submission
- Yes
- Statement period
- 1 July 2024 – 30 June 2025
- Approved
- 1 July 2025
- Sectors
- Healthcare and pharmaceuticals
Organisation structure
Covered in the statement
Policies
Covered in the statement
Risk assessment
Covered in the statement
Due diligence
Covered in the statement
Training
Covered in the statement
Goals and KPIs
Covered in the statement
Full statement information supplied to the registry
- Reported turnover band
- Over £500 million
- Years producing statements
- More than 5 years
- ILO indicators included
- Not answered
- Registry record updated
- 22 September 2025
A registry entry records what the organisation declared in its statement. It is not an independent audit. Group statements can cover several companies; BritDB preserves each exact source-supplied company-number link and excludes approver names and email addresses.
06 Data protection
ICO fee-payer registration
UCB Pharma Limited
Registration Z5734966
- Registered from
- 11 September 2001
- Current end date
- 10 September 2026
This is a candidate association, not an official Companies House link. The ICO file supplies no company number. The organisation name and postcode uniquely matched this company in the current snapshot. BritDB excludes all DPO contact fields and does not publish unmatched personal entries.
07 Public procurement
Contracts Finder awards
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche
NHS England · ocds-b5fd17-711f74f7-430c-4b80-a5e0-b3ce69f928b9
- Supplier named in award
- UCB Pharma Ltd
- Award value
- £1
- Contract period
- 1 March 2021 – 28 February 2023
- Published
- 13 May 2021
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-711f74f7-430c-4b80-a5e0-b3ce69f928b9-2021-05-13T10:21:38+01:00
NHS Framework for the Midlands and East, Branded Medicines - Tranche B
NHS England · ocds-b5fd17-a3813112-7a5b-461b-9e42-ccdb117c93ef
- Supplier named in award
- UCB Pharma Ltd
- Award value
- £228,156,862
- Contract period
- 1 March 2021 – 28 February 2023
- Published
- 30 April 2021
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-a3813112-7a5b-461b-9e42-ccdb117c93ef-2021-04-30T13:00:26+01:00
NHS Framework for the NHS London Region, Branded Medicines - Tranche A
NHS England · ocds-b5fd17-20ae12c6-3ba8-40bb-b423-51a2c2de6a67
- Supplier named in award
- UCB Pharma Ltd
- Award value
- £191,062,951
- Contract period
- 1 September 2020 – 31 August 2022
- Published
- 15 September 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-20ae12c6-3ba8-40bb-b423-51a2c2de6a67-2020-09-15T14:26:04+01:00
NHS Framework Agreement - North of England - Tranche B
NHS England · ocds-b5fd17-2774d91d-05e7-400d-a217-4a5ca9db01ef
- Supplier named in award
- UCB PHARMA LIMITED
- Award value
- £205,535,556
- Contract period
- 1 March 2020 – 28 February 2022
- Published
- 25 March 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-2774d91d-05e7-400d-a217-4a5ca9db01ef-2020-03-25T08:39:13Z
NHS Midlands and East Branded Medicines - Tranche A
NHS England · ocds-b5fd17-1d021051-40c8-4883-ba04-47625826b7b8
- Supplier named in award
- UCB PHARMA LTD
- Award value
- £418,787,000
- Contract period
- 1 March 2020 – 28 February 2022
- Published
- 13 February 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-1d021051-40c8-4883-ba04-47625826b7b8-2020-02-13T09:40:57Z
NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice
NHS England · ocds-b5fd17-8b5e045d-6a03-4c26-b452-fcd5b23d5349
- Supplier named in award
- UCB PHARMA LIMITED
- Award value
- £188,004,961
- Contract period
- 1 September 2019 – 31 August 2021
- Published
- 17 October 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-8b5e045d-6a03-4c26-b452-fcd5b23d5349-2019-10-17T10:16:17+01:00
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity
NHS England · ocds-b5fd17-aaa2bd9e-0fdb-4884-8fca-b0d29a6ed15a
- Supplier named in award
- UCB Pharma Ltd
- Award value
- £251,930,337
- Contract period
- 1 September 2019 – 31 August 2020
- Published
- 1 October 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-aaa2bd9e-0fdb-4884-8fca-b0d29a6ed15a-2019-10-01T15:57:02+01:00
NHS Framework Agreement for Branded Medicines - National
NHS England · ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7
- Supplier named in award
- UCB Pharm Ltd
- Award value
- £1,351,341,890
- Contract period
- 1 May 2019 – 30 April 2021
- Published
- 9 August 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7-2019-08-09T15:57:38+01:00
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England · ocds-b5fd17-6c7a4e2c-58d3-4c41-8f77-dc419f83871c
- Supplier named in award
- UCB Pharma Ltd 208 Bath Road, Slough, Berkshire, SL1 3WE
- Award value
- £295,035,882
- Contract period
- 1 March 2019 – 28 March 2021
- Published
- 9 April 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-6c7a4e2c-58d3-4c41-8f77-dc419f83871c-2019-04-09T11:25:43+01:00
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England · ocds-b5fd17-9878d09a-d11a-4940-a851-2b2b759217f2
- Supplier named in award
- UCB Pharma Ltd 208 Bath Road, Slough, Berkshire, SL1 3WE
- Award value
- £295,035,882
- Contract period
- 1 March 2019 – 28 March 2021
- Published
- 9 April 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-9878d09a-d11a-4940-a851-2b2b759217f2-2019-04-09T11:04:50+01:00
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England · ocds-b5fd17-679e36df-b147-44d9-b0c1-53e4b91250c8
- Supplier named in award
- UCB Pharma Ltd 208 Bath Road, Slough, Berkshire, SL1 3WE
- Award value
- £295,035,882
- Contract period
- 1 March 2019 – 28 March 2021
- Published
- 9 April 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-679e36df-b147-44d9-b0c1-53e4b91250c8-2019-04-09T10:58:14+01:00
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England · ocds-b5fd17-8aaddf75-dd22-4754-b241-885b44819814
- Supplier named in award
- UCB Pharma Ltd 208 Bath Road, Slough, Berkshire, SL1 3WE
- Award value
- £295,035,882
- Contract period
- 1 March 2019 – 28 March 2021
- Published
- 21 March 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-8aaddf75-dd22-4754-b241-885b44819814-2019-03-21T11:50:47Z
NHS England Framework Agreement: South of England (Tranche B)
NHS England · ocds-b5fd17-3dac71e6-cde5-406b-abc4-e91389859bf5
- Supplier named in award
- UCB PHARMA LTD
- Award value
- £501,400,000
- Contract period
- 1 September 2018 – 31 August 2020
- Published
- 1 October 2018
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-3dac71e6-cde5-406b-abc4-e91389859bf5-2018-10-01T08:55:31+01:00
The supplier link is exact, but the award remains buyer-published procurement data. BritDB requires the GB-COH identifier supplied in the Contracts Finder OCDS release and does not infer suppliers from similar names.
TM UK trade marks
Exact owner-name matches
SELECTAJET
Owner UCB Pharma Limited · classes 5,10
- Filed / designated
- 26 November 2010
- Valid until / renewal due
- 26 November 2020
METADATE
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 27 July 1999
- Valid until / renewal due
- 27 July 2019
CORACTEN XL
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 1 August 1997
- Valid until / renewal due
- 1 August 2027
MINIJET
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 17 August 1994
- Valid until / renewal due
- 17 August 2021
CORACTEN
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 1 October 1985
- Valid until / renewal due
- 1 October 2026
DIOCTYL
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 6 October 1981
- Valid until / renewal due
- 6 October 2022
MEDOCODENE
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 20 June 2005
- Valid until / renewal due
- 20 June 2015
OSMOLAX
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 1 August 2001
- Valid until / renewal due
- 1 August 2011
LAXAMAX
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 15 June 2001
- Valid until / renewal due
- 15 June 2011
LAX-MAX
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 15 June 2001
- Valid until / renewal due
- 15 June 2011
CORACTEN LA
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 11 July 1996
- Valid until / renewal due
- 11 July 2006
MINIJET
Owner UCB Pharma Limited · classes 10
- Filed / designated
- 31 October 1994
- Valid until / renewal due
- 31 October 2014
MENZOL
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 7 April 1987
- Valid until / renewal due
- 7 April 2008
DERMACAINE
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 6 October 1981
- Valid until / renewal due
- 6 October 2012
HORMOFEMIN
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 6 October 1981
- Valid until / renewal due
- 6 October 2012
MediPharm
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 13 December 1978
- Valid until / renewal due
- 13 December 2009
MEDDOCODENE
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 13 July 1964
- Valid until / renewal due
- 13 July 2009
PULMODRINE
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 30 May 1957
- Valid until / renewal due
- 30 May 2016
HYPERTANE
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 25 June 1954
- Valid until / renewal due
- 25 June 2013
INSOMNOL
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 30 January 1953
- Valid until / renewal due
- 30 January 2012
TONIVITAN.
Owner UCB Pharma Limited · classes 5
- Filed / designated
- 31 August 1945
- Valid until / renewal due
- 31 August 2008
This is an exact normalised company-name match, not a registrar-confirmed ownership link. Another legal entity can have the same or a very similar name. UKIPO data is a historical 2018 snapshot; verify the owner and current status before relying on it.
08 Ownership and control
People with significant control
Celltech Group Limited
- Owns 75% or more of shares
- Controls 75% or more of voting rights
- Can appoint or remove directors
- Country registered
- United Kingdom
- Legal authority
- Companies Act 2006
- Legal form
- Company Limited By Shares
- Place registered
- Companies House
- Registration number
- 02159282
- Notified
- 6 April 2016
PSC records are company-filed public-register information. When the exact same displayed individual name occurs at multiple companies, BritDB offers a non-indexed cross-reference page. It is a name match only, not proof that the records describe the same person. Service addresses and partial dates of birth are deliberately omitted.
09 Charity register
Charity Commission links
No exact company-number link in this snapshot
The Charity Commission extract did not explicitly associate this Companies House number with a charity. BritDB does not use a name-only match to fill the gap.
This company-level check covers the Charity Commission for England and Wales. Links are accepted only when the official extract supplies this exact company registration number. Scottish charities now have separate OSCR profiles, but OSCR’s bulk fields do not provide a Companies House number, so BritDB does not infer a company link.
10 Northern Ireland charity register
CCNI exact company links
No unambiguous company-number link found
The CCNI source number did not resolve uniquely to this Companies House record. BritDB did not use a name or address match.
CCNI publishes company numbers without a jurisdiction prefix. BritDB links only when the plausible padded UK and NI candidates resolve to exactly one Companies House company.
11 Sanctions screening
UK Sanctions List
No exact business-registration-number link found
The imported UK Sanctions List did not supply this Companies House number as a UK-linked business identifier. BritDB did not attempt a name-only match.
No exact link is not sanctions clearance. UK restrictions can apply through ownership or control even where an entity is not separately named. Always use the current official list and obtain appropriate advice for a legally significant decision.
12 Public procurement
Find a Tender links
No exact GB-COH link in this snapshot
Find a Tender did not explicitly identify this Companies House number in a procurement party. BritDB did not attempt a name-only match.
These links use only the GB-COH identifier supplied in the procurement record. A company may have other public-sector work that is absent, older, below publication thresholds or published without a Companies House identifier.
13 Environmental register
Environment Agency waste registrations
No exact company-number registration linked
The licensed Environment Agency subset did not contain this exact Companies House number. BritDB did not attempt a name-only match.
This is a privacy-reduced, exact-company subset. The full official register also includes sole traders and applicants without a matching Companies House number. Check the current Environment Agency register before relying on registration status.
14 Nature of business
Standard Industrial Classification
15 Connected public record
Checks beyond the company register
Charity Commission
0 exact company-number links.
Northern Ireland charities
0 unambiguous company-number links.
Public contracts
0 procurement processes linked by exact GB-COH identifier.
Waste register
0 exact company-number registrations.
Corporate notices
The Gazette is not yet connected.
UK Sanctions List
No exact business-registration-number link in this report.
A checked source with no exact link is not a clean bill of health. Unchecked sources remain unknown, while sanctions may also apply through ownership or control of a listed person or entity.
16 Record timeline
Dates in the bulk record
- Confirmation statement
Latest confirmation statement made up to this date
- Accounts
Latest accounts made up to this date
- Incorporation
Company incorporated
17 Provenance
Sources for this profile
Identity, address, status, dates, SIC, previous names and mortgage totals.
Statutory supplier-payment reports linked by the exact source-supplied Companies House number.
Global legal identities linked through Companies House registration authority RA000585.
Annual statement summaries linked by exact source company number.
Privacy-reduced candidate associations based on a unique exact name-and-postcode match.
Historic awards linked by exact source-supplied GB-COH company identifier.
Current and ceased significant-control records joined by exact company number.
Daily England and Wales extract matched only by the official company registration number.
Daily CCNI export with company links only where the source number resolves unambiguously.
Complete FCDO list checked by exact UK-linked business registration number.
Procurement parties checked only through exact GB-COH identifiers.
Licensed subset linked only by exact Companies House number.
Financial regulation and licences.
Companies House, Charity Commission, OSCR and UK Sanctions List information is public-register data. BritDB reproduces and organises it with source-specific limits; official external links are kept on the dedicated source pages.